• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18
Mike Doustdar Novo Nordisk Novo Novo CEO
Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner Jun 11, 2026 7:00am
ASCO 2026 showed that precision oncologys next challenge is translation

Precision oncology’s next challenge is translation

Brought to you by Thermo Fisher Scientific
German flag

Germany scraps variable discount plan meant to cut costs: report

Jun 15, 2026 3:30pm
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
Food and Drug Administration

Regulatory tracker: AZ's Truqap clears hurdle in prostate cancer

Jun 15, 2026 2:18pm
European Commission Approves CinnaGens Zandoriah teriparatide biosimilar for Osteoporosis in Adults

European Commission Approves CinnaGen’s Zandoriah (teriparatide)

Brought to you by CinnaGen
More News

Merck's Welireg expands in kidney cancer with adjuvant nod

Jun 15, 2026 11:46am

IQVIA taps AI to put overlooked prescribers on marketers’ maps

Jun 15, 2026 11:44am

After 2-month delay, Sanofi gains FDA expansion for Tzield

Jun 15, 2026 11:25am

Eisai gets UK backing as it expands plant for Leqembi production

Jun 15, 2026 10:20am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings